re: "FYI - Product is on the market - OTC product. Not sure what your debating here. It wouldnt have gotten to phase 3 it showed minimal results. Lets just both admit we saw this today rather then at 0.066"
The product on the market, Travelan, t is meant to be taken before each meal. The DoD has said this is impractical as it's too burdensome to take a pill 3 times a day. So IMC created a new formulation meant to be taken once a day. This is what the study is about.
